[{"uuid": "c2861abe-a9da-3e04-bb40-fee3054f2ad7", "title": "Dermata to Present on BioPub on January 31, 2025", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/dermata-present-biopub-january-31-210500764.html", "providerPublishTime": 1738184700, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.ddRHF0UKcHn1infwaQ9UQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/gDZwbjRdnA3k8_rIHS7zrQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DRMA", "DRMAW"]}, {"uuid": "76838474-e3e4-31cc-a47b-5be1755c1be5", "title": "Dermata Expands Patent Portfolio with Issuance of New U.S. Patent for Next-Generation Acne Treatment", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/dermata-expands-patent-portfolio-issuance-210500676.html", "providerPublishTime": 1738098300, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.ddRHF0UKcHn1infwaQ9UQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/gDZwbjRdnA3k8_rIHS7zrQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 140, "height": 140, "tag": "140x140"}]}}, {"uuid": "6c59035a-abd0-3dd5-965a-ef4359c0ab8a", "title": "Dermata Therapeutics Announces Closing of $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/dermata-therapeutics-announces-closing-2-211500772.html", "providerPublishTime": 1737666900, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.ddRHF0UKcHn1infwaQ9UQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/gDZwbjRdnA3k8_rIHS7zrQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DRMA", "DRMAW"]}, {"uuid": "4915a365-e63b-32b4-8837-ede7448fcf10", "title": "Dermata Therapeutics Announces $2.55 Million Private Placement Priced At-The-Market Under Nasdaq Rules", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/dermata-therapeutics-announces-2-55-130000738.html", "providerPublishTime": 1737550800, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.ddRHF0UKcHn1infwaQ9UQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/gDZwbjRdnA3k8_rIHS7zrQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DRMA", "DRMAW"]}, {"uuid": "8621c3e5-88eb-3e16-8222-7f774b7ff4e9", "title": "Dermata, Revance Collaborate on Trial to Treat Chronic Armpit Sweating", "publisher": "MT Newswires", "link": "https://finance.yahoo.com/news/dermata-revance-collaborate-trial-treat-152812459.html", "providerPublishTime": 1737473292, "type": "STORY", "relatedTickers": ["DRMAW", "RVNC"]}, {"uuid": "5ef23cb9-aecb-3861-bbb7-2f5cfa42cfb1", "title": "Area manufacturers need skilled workers. 'If people go away, the future goes away.'", "publisher": "Springfield News-Sun, Ohio", "link": "https://finance.yahoo.com/m/5ef23cb9-aecb-3861-bbb7-2f5cfa42cfb1/area-manufacturers-need.html", "providerPublishTime": 1737521940, "type": "STORY"}, {"uuid": "ea7ce0ae-4773-3a1e-8d70-0f027aba0516", "title": "Dermata and Revance Enter Clinical Trial Collaboration Agreement for the Topical Application of Xyngari(TM) with Daxxify(R)", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/dermata-revance-enter-clinical-trial-130000355.html", "providerPublishTime": 1737464400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.ddRHF0UKcHn1infwaQ9UQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/gDZwbjRdnA3k8_rIHS7zrQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DRMA", "DRMAW"]}, {"uuid": "a5886f58-d25f-3f26-ad3c-f6bf18f8f27c", "title": "Dermata Receives Approval from FDA for the Proprietary Name Xyngari(TM)", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/dermata-receives-approval-fda-proprietary-140000682.html", "providerPublishTime": 1734357600, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.ddRHF0UKcHn1infwaQ9UQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/gDZwbjRdnA3k8_rIHS7zrQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DRMA", "DRMAW"]}, {"uuid": "00c40a70-1e7a-3866-913c-d617bf4c5177", "title": "Dermata Receives Notice of Allowance for New U.S. Patent for DMT310 for the Treatment of Acne", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/dermata-receives-notice-allowance-u-140000411.html", "providerPublishTime": 1733839200, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.ddRHF0UKcHn1infwaQ9UQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/gDZwbjRdnA3k8_rIHS7zrQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DRMA", "DRMAW"]}, {"uuid": "7e2d067e-05a7-3fce-bd22-4ad148504fc5", "title": "Dermata Completes Enrollment in First Pivotal DMT310 Phase 3 STAR-1 Clinical Trial for Acne", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/dermata-completes-enrollment-first-pivotal-140000407.html", "providerPublishTime": 1733234400, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.ddRHF0UKcHn1infwaQ9UQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/gDZwbjRdnA3k8_rIHS7zrQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DRMA", "DRMAW"]}, {"uuid": "1252e98c-76b4-314f-ab00-74f8dd8500c9", "title": "Dermata Therapeutics to Present at the Life Sciences Investor Forum on Thursday, November 14, 2024", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/dermata-therapeutics-present-life-sciences-133500595.html", "providerPublishTime": 1731332100, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/pFljWkapktZgUPklKmqXAw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c1bc32f339f4e97512173ec64c4449c0", "width": 600, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/DtOSOrQHkCaAwVRwOODo5g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/c1bc32f339f4e97512173ec64c4449c0", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DRMA", "DRMAW"]}, {"uuid": "2f0c4d38-e848-3a83-afea-b9d875ec64bf", "title": "Dermata Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results", "publisher": "ACCESS Newswire", "link": "https://finance.yahoo.com/news/dermata-therapeutics-provides-corporate-reports-211500633.html", "providerPublishTime": 1731532500, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/.ddRHF0UKcHn1infwaQ9UQ--~B/aD00MDA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 400, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/gDZwbjRdnA3k8_rIHS7zrQ--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/accesswire.ca/4a28447ff42546b492c673d272410285", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DRMA", "DRMAW"]}, {"uuid": "00529243-4085-30cb-9258-ca384653b847", "title": "Life Sciences Investor Forum: Presentations Now Available for Online Viewing", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/life-sciences-investor-forum-presentations-133500021.html", "providerPublishTime": 1731677700, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/pFljWkapktZgUPklKmqXAw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c1bc32f339f4e97512173ec64c4449c0", "width": 600, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/DtOSOrQHkCaAwVRwOODo5g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/c1bc32f339f4e97512173ec64c4449c0", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["DRMA", "DRMAW", "NRBO", "ZVSA", "MBCOF", "CGTX"]}, {"uuid": "a93d8f1b-2c17-3f0b-8896-2f0d93dfb225", "title": "Life Sciences Investor Forum Agenda Announced for November 14th", "publisher": "GlobeNewswire", "link": "https://finance.yahoo.com/news/life-sciences-investor-forum-agenda-133500963.html", "providerPublishTime": 1731418500, "type": "STORY", "thumbnail": {"resolutions": [{"url": "https://s.yimg.com/uu/api/res/1.2/pFljWkapktZgUPklKmqXAw--~B/aD00MDA7dz02MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/globenewswire.com/c1bc32f339f4e97512173ec64c4449c0", "width": 600, "height": 400, "tag": "original"}, {"url": "https://s.yimg.com/uu/api/res/1.2/DtOSOrQHkCaAwVRwOODo5g--~B/Zmk9ZmlsbDtoPTE0MDtweW9mZj0wO3c9MTQwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/globenewswire.com/c1bc32f339f4e97512173ec64c4449c0", "width": 140, "height": 140, "tag": "140x140"}]}, "relatedTickers": ["ZVSA", "NRBO", "DRMA", "DRMAW", "CGTX"]}]